Advertisement Palomar and Q-Med terminate distribution agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Palomar and Q-Med terminate distribution agreement

US-based Palomar Medical Technologies, a developer of light-based systems for cosmetic treatments, has terminated its international distribution agreement with Q-Med, a medical device company based in Uppsala, Sweden.

The international distribution agreement was originally entered into in January 2008 with the intention that Q-Med would eventually be responsible for the marketing, advertising, promotion, sale and distribution of Palomar’s professional products for aesthetic treatments outside North America.

Due to the downturn in the world-wide economic environment, Q-Med’s efforts are being concentrated on their own product line of dermal fillers. Both Palomar and Q-Med agreed that Palomar will be better served by separately continuing to expand its existing distribution channel.

Joseph Caruso, CEO of Palomar, said: “Although we are choosing to end our distribution agreement, this was a good learning experience and we have forged a positive relationship with Q-Med that may be beneficial in the future. We have signed up many new distributors over the past 12 months and continue to work closely with all of our distributors to help maximize their sales efforts.”